This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Inovio Pharmaceuticals, Inc., University of Pennsylvania. Active years: 2014-2015.
Company Filing History:
2 out of 93 
2 out of 2,651 
Years Active: 2014-2015
Title: Krystle A Lang: Innovator in HCV Vaccine Development
Introduction
Krystle A Lang is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of vaccine development, particularly in the fight against Hepatitis C Virus (HCV). With a total of 2 patents, her work focuses on improving immunogens and methods for inducing immune responses against HCV.
Latest Patents
Lang's latest patents include innovative approaches to HCV vaccines and methods for their use. These patents disclose improved anti-HCV immunogens and nucleic acid molecules that encode them. The immunogens include those having consensus HCV genotype 1a/1b NS3 and NS4A. Additionally, her patents cover pharmaceutical compositions, recombinant vaccines, and live attenuated vaccines. Methods for inducing an immune response in individuals against HCV are also detailed in her work.
Career Highlights
Throughout her career, Krystle A Lang has worked with esteemed institutions such as the University of Pennsylvania and Inovio Pharmaceuticals, Inc. Her research has been pivotal in advancing the understanding and treatment of HCV.
Collaborations
Lang has collaborated with notable colleagues, including David B Weiner and Jian Yan. These partnerships have further enhanced her research and contributions to the field.
Conclusion
Krystle A Lang's innovative work in HCV vaccine development showcases her dedication to improving public health. Her patents and collaborations reflect her significant impact in the field of immunology.